
|Articles|February 24, 2014 (Updated: April 18, 2020)
- Gastrointestinal Cancers (Issue 1)
- Volume 1
- Issue 1
The Treatment of Advanced Colorectal Cancer
Author(s)Roberto Bordonaro, MD
Roberto Bordonaro, MD, chair, medical oncology, Garibaldi Hospital, Catania, Italy, discusses the treatment of patients with advanced colorectal cancer.
Roberto Bordonaro, MD, chair, medical oncology, Garibaldi Hospital, Catania, Italy, discusses the treatment of patients with advanced colorectal cancer (CRC).
Read more about the treatment of CRC andthe need for fullRASmutational analyses > >
Articles in this issue
about 12 years ago
The Identification of Molecular Subtypes of Gastric Cancerabout 12 years ago
Ramucirumab Combo Increases Survival in Gastric Cancerabout 12 years ago
<em>RAS</em> Status Matters in mCRC: Confirmed by Second-Line Dataabout 12 years ago
New Standard of Neoadjuvant Care for Rectal Cancer Establishedabout 12 years ago
Reducing the Risk of Relapse in Patients With Pancreatic Cancerabout 12 years ago
Vismodegib Demonstrates Activity in Advanced Pancreatic Cancerabout 12 years ago
TTP, OS Benefit Seen Following Treatment With TGF-β Inhibitor in HCCRelated Content
Advertisement



mFOLFOX/Bevacizumab/Atezolizumab Improves PFS in dMMR/MSI-H Colorectal Cancer
Published: | Updated:





























